Genetic prior authorization waiver expiring

Last modified: November 10, 2021

On June 1, 2021, we began transitioning genetic testing to the new Prior Authorization and Notification platform. Since the transition began, we have offered a prior authorization penalty waiver for genetic and molecular tests.

Beginning Jan. 1, 2022, the penalty waiver will no longer be in effect. This means that, for those genetic and molecular tests that require prior authorization/advanced notification, ordering providers must request prior authorization using the Prior Authorization and Notification platform or by calling 877-303-7736.

Performing laboratories are able to submit advance notifications. If a test requires prior authorization with clinical criteria, the request must be submitted by the ordering provider.

For the current list of genetic and molecular tests that require prior authorization/advance notification, please go to UHCprovider.com/paan > Advance Notification and Plan Requirement Resources.

Prior authorization/advance notification training

United Healthcare is offering live training sessions for the Genetic and Molecular Testing Prior Authorization/Advance Notification (PAAN) program. To register for training, please visit the UnitedHealthcare genetic and molecular testing prior authorization/advance notification (PAAN) web page.

Questions?

For more information about the genetic and molecular lab testing prior authorization/advance notification program, please visit the UnitedHealthcare genetic and molecular testing prior authorization/advance notification (PAAN) web page and review the genetic and molecular lab testing PAAN FAQs.

PCA-1-21-03924-Clinical-News_10282021